Correction: Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer

PLoS One. 2024 Dec 12;19(12):e0315976. doi: 10.1371/journal.pone.0315976. eCollection 2024.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0301271.].

Publication types

  • Published Erratum